SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICN Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: I8IT who wrote (963)4/14/1999 6:03:00 PM
From: Clouseau  Respond to of 1029
 
Thread - If you aren't aware, most active posters on ICN have migrated to RagingBull...

I agree with you, certainly momentum is building; look at today's volume!

Dave



To: I8IT who wrote (963)4/14/1999 10:13:00 PM
From: Michael Young  Read Replies (1) | Respond to of 1029
 
<<Apparently Warburg has a $45 price target on the stock. ICN is just too cheap at 14 times 1999 eps. Rebetron sales are lokking real good. I think we have a winner here.>>

Warburg apparently has a $50 target now. Gene Melnitchenko of Sutro is carrying a $85 target.

MIKE


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News